M Soulié

Author PubWeight™ 28.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology]. Prog Urol 2009 1.40
2 Haemodynamic changes during retroperitoneoscopic adrenalectomy for phaeochromocytoma. Br J Anaesth 2001 1.38
3 Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma. Radiother Oncol 1999 0.95
4 Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol 2001 0.95
5 [CCAFU Recommendations 2013: Renal cancer]. Prog Urol 2013 0.87
6 [Characteristics of prostate cancer in men less than 50-year-old]. Prog Urol 2009 0.86
7 Medical and non-medical determinants of prostate cancer management: a population-based study. Eur J Cancer 2003 0.86
8 [Prospective study of the results of ureterointestinal anastomosis in 100 patients after the Hautmann ileal neobladder with double chimney]. Prog Urol 2011 0.85
9 [Recommendations Onco-Urology 2010: Prostate cancer]. Prog Urol 2010 0.85
10 [Malignant tumors of the adrenal: contribution to the repository CCAFU INCa]. Prog Urol 2010 0.84
11 [CCAFU Recommendations 2013: Prostate cancer]. Prog Urol 2013 0.83
12 Experience with retroperitoneal laparoscopic adrenalectomy in 115 procedures. J Urol 2001 0.82
13 [Projected incidence and mortality from urologic cancer in France in 2010.]. Prog Urol 2010 0.81
14 [Recommendations Onco-Urology 2010: Kidney cancer]. Prog Urol 2010 0.81
15 [Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology]. Prog Urol 2010 0.80
16 [Fusion genes and prostate cancer. From discovery to prognosis and therapeutic perspectives]. Prog Urol 2009 0.80
17 [Combined glaucoma and diabetic retinopathy screening in Burgundy]. J Fr Ophtalmol 2008 0.80
18 [Laparoscopy-assisted vaginal pelvic exenteration]. Gynecol Obstet Fertil 2006 0.80
19 [Recommendations Onco-Urology 2010: Malignancies of the penis]. Prog Urol 2010 0.80
20 [First line indications for hormonal therapy in prostate cancer]. Prog Urol 2009 0.79
21 [CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers]. Prog Urol 2013 0.79
22 [CCAFU Recommendations 2013: Bladder carcinoma]. Prog Urol 2013 0.79
23 [Recommendations Onco-Urology 2010: Germ cell testicular tumors.]. Prog Urol 2010 0.79
24 [Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma]. Prog Urol 1999 0.78
25 [Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases]. Prog Urol 2008 0.78
26 [T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU)]. Prog Urol 2010 0.78
27 [Migration of pathological stage after radical prostatectomy to higher risk tumors of relapse: comparative two-center study between 2005 and 2010]. Prog Urol 2012 0.78
28 [Status and medicolegal implications in France pT0 stage of prostate cancer: a study by the CC-AFU]. Prog Urol 2012 0.78
29 [Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle invasive bladder cancer]. Prog Urol 2012 0.77
30 [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm]. Prog Urol 2011 0.77
31 [Transurethral resection (TUR) in saline plasma vaporization of the prostate versus standard TUR of the prostate: an economic evaluation]. Prog Urol 2012 0.77
32 [Benefit of bladder and upper urinary tract urothelial tumors lymph node dissection: review from the Bladder Cancer Committee of the French National Association of Urology ("CC-AFU Vessie")]. Prog Urol 2012 0.77
33 [Local staging of prostate carcinoma with phased array MR imaging: prospective study over 5 years]. J Radiol 2002 0.76
34 [Urothelial carcinoma in patients under 40 years. Review of the cancer committee of the French Association of Urology]. Prog Urol 2013 0.76
35 [Recommendations Onco-Urology 2010: Urothelial tumors]. Prog Urol 2010 0.75
36 [What's new in 2008 in the field of basic and clinical research in prostate cancer?]. Prog Urol 2009 0.75
37 [Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers]. Prog Urol 1997 0.75
38 [Prevention of sterility in spinal cord injured men]. Prog Urol 1997 0.75
39 Re: Giant scrotal lipomatosis. J Urol 1997 0.75
40 [Do broader indications for partial nephrectomy result in excess morbidity?]. Prog Urol 2008 0.75
41 [The role and method of fluorescence-guided cystoscopy in 2011 for management of bladder cancer: Review of the Oncology Committee of the French Urology Association]. Prog Urol 2011 0.75
42 [Role of the multidisciplinary structured and adjusted management...]. Prog Urol 2009 0.75
43 [New perspectives in prostate cancer management]. Prog Urol 2010 0.75
44 Pubourethral ligaments in women: anatomical and clinical aspects. Surg Radiol Anat 2002 0.75
45 [Fertility after prostate brachytherapy with Iode 125 permanent implants for localized prostate cancer]. Prog Urol 2011 0.75
46 [Treatment of infiltrating nonmetastatic bladder cancers in elderly patients]. Prog Urol 2009 0.75
47 [Critic analysis of a comparative meta-analysis on the morbidity, functional and carcinologic results after radical prostatectomy according to surgical approach. Work of cancerology committee of the French urological association]. Prog Urol 2010 0.75
48 [Diagnostic test for bladder cancer: the NMP22®]. Prog Urol 2011 0.75
49 [Medical castration in the treatment of locally advanced or metastatic prostate cancer: an update]. Prog Urol 2009 0.75
50 [The place of laparoscopic nephrectomy in the elderly subject]. Prog Urol 2009 0.75
51 [A case of free-living Amoebae keratitis in a non contact lens wearer]. Ann Biol Clin (Paris) 2005 0.75
52 [Retroperitoneal sarcoma: contribution to the repository CCAFU INCA.]. Prog Urol 2010 0.75
53 [High-risk prostate cancer. Review by the Oncology Committee of the French Urology Association]. Prog Urol 2011 0.75
54 [What's new in 2009 about urothelial tumors? Live from EAU, AUA and ASCO, ASCO-GU]. Prog Urol 2010 0.75
55 [Retroperitoneal laparoscopic adrenalectomy: a safe and reproducible technique]. Prog Urol 2001 0.75
56 [What's new in 2009 in prostate cancer: highlights from ASTRO, EAU, ASCO and AUA meetings]. Prog Urol 2010 0.75
57 [Analysis of the evolution of surgery for the treatment of primary renal tumors during the period 2006-2010: report of 458 consecutive surgeries]. Prog Urol 2012 0.75
58 [Do ablative treatments modify the management of kidney tumors in the elderly?]. Prog Urol 2009 0.75
59 [Lymphadenectomy and prostate cancer: a statement of the committee of cancerology of the French Association of Urology]. Prog Urol 2012 0.75
60 [Tribute to Jean-Louis Davin (1953-2016)]. Prog Urol 2016 0.75
61 Is there a volume-outcome relationship for partial nephrectomy? World J Urol 2013 0.75
62 [Prostate cancer 2010. Therapeutic innovations]. Cancer Radiother 2011 0.75
63 [Prostate brachytherapy: indications and outcomes]. Prog Urol 2013 0.75
64 [Chemotherapy in perioperative setting for infiltrative bladder cancer]. Prog Urol 2011 0.75
65 [Large-cell calcifying Sertoli cell tumors: apropos of a case and review of the literature]. Prog Urol 1999 0.75
66 [Results of total prostatectomy in the elderly patient]. Prog Urol 2009 0.75
67 [Should we consider a complementary treatment after a renal colic drained by an ureteral stent?]. Prog Urol 2012 0.75
68 [Does cancer surgery in elderly patients present special issues?]. Prog Urol 2009 0.75
69 [Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990]. Prog Urol 1997 0.75
70 [The 2010 news: highlights of the ASCO-GU, UAE, ASCO, AUA congress…]. Prog Urol 2011 0.75
71 [Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology]. Prog Urol 2012 0.75
72 [Androgen suppression for the treatment of prostate cancer in the elderly]. Prog Urol 2009 0.75
73 [Natural history and management of retroperitoneal sarcoma: Review of the literature by the Oncology committee of the French association of urology]. Prog Urol 2011 0.75
74 [Active surveillance for localized prostate cancer]. Prog Urol 2011 0.75
75 [5 alpha-reductase inhibitors and prostate cancer: a statement of the Committee of Cancerology of the French Association of Urology]. Prog Urol 2012 0.75
76 [Urethral instability]. Prog Urol 2000 0.75
77 [CCAFU Recommendations 2013: Upper urinary tract carcinoma]. Prog Urol 2013 0.75
78 [Renal adenocarcinoma with retrohepatic vena cava thrombus: role of extracorporeal circulation in a retrospective series of 10 cases]. Prog Urol 1999 0.75
79 [Standards, options, and recommendation for external radiotherapy of prostatic cancer: evaluation of the effect of dosage]. Cancer Radiother 2002 0.75
80 [Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer]. Prog Urol 2010 0.75
81 [Urologic aspects of Polyomavirus infection]. Prog Urol 2009 0.75
82 [Prostate cancer, androgenic suppression and associated conditions. Practical refinement by a panel of multidisciplinary experts for patient integral management]. Prog Urol 2012 0.75
83 [Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology]. Prog Urol 2011 0.75
84 [The use of MRI with a pelvic phased array antenna in the evaluation of the gland and tumor volume of clinically localized prostatic adenocarcinoma]. Prog Urol 1998 0.75
85 [Ureteral and vesicular endometriosis: case report]. Prog Urol 1999 0.75
86 [The role and principles of radiotherapy in prostate cancer in the elderly subject]. Prog Urol 2009 0.75
87 [Is there a role for pelvic lymphadenectomy before radiation therapy in localized prostate carcinoma?]. Cancer Radiother 2013 0.75
88 [Completeness and quality of multidisciplinary team meetings: the example of prostate cancer in the Mid-Pyrenees region]. Prog Urol 2011 0.75
89 [Postchemotherapy retroperitoneal lymphadenectomy for testicular cancer. Literature review by the Oncology Committee of the French Association of Urology, External Genitalia Group]. Prog Urol 2011 0.75